# US 2025/0146060 A1 · Echo amplification: a comprehensive system of chemistry and methods for amplification and detection of specific nucleic acid sequences

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146060 A1
- Document ID: US20250146060A1
- Status: Published application
- Kind: A1
- Application number: 18/691,007
- Filed: 2022-09-15
- Published: 2025-05-08
- Earliest claimed: 2021-09-16
- Assignees: Cepheid
- Applicants: Cepheid
- Inventors: Glenn C. Johns; Carla Maria McDowell-Buchanan; Vera Baraznenok
- Web page: https://patentgrep.com/patent/US20250146060A1

## CPC

- C12Q 1/686: Polymerase chain reaction [PCR]
- C12N 9/1252: {DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase}
- C12N 9/16: acting on ester bonds (3.1)
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12Q 1/6813: Hybridisation assays
- C12Q 1/6853: using modified primers or templates
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Y 207/07007: DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

Described herein is a comprehensive novel amplification system that can employ novel nucleic acid constructs as blocked primers, such constructs including a target-specific region, wherein the target-specific region comprises a target-specific cleavage domain, and a universal adapter sequence located 5′ of the target-specific region, wherein the universal adapter sequence comprises a non-natural nucleotide base. Also described is a fusion protein between a polymerase and an endonuclease, which is useful in this system, as well as related methods and kits.

## Claims

### Claim 1

A nucleic acid construct comprising:
a target-specific region; and,
a universal adapter sequence located 5′ of the target-specific region, wherein the universal adapter sequence comprises a non-natural nucleotide base.

### Claim 2 (depends on 1)

The nucleic acid construct of claim 1, wherein the nucleic acid construct additionally comprises a terminal 3′ cap.

### Claim 3 (depends on 1, 2)

The nucleic acid construct of claim 1 or claim 2, wherein the target-specific region comprises a target-specific cleavage domain.

### Claim 4 (depends on 3)

The nucleic acid construct of claim 3, wherein the target-specific cleavage domain comprises a ribonucleotide.

### Claim 5 (depends on 1, 2, 3, 4)

The nucleic acid construct of any one of claims 1-4, wherein the non-natural nucleotide base is a ribonucleotide.

### Claim 6 (depends on 1, 2, 3, 4)

The nucleic acid construct of any one of claims 1-4, where in the non-natural nucleotide base is a deoxyribonucleotide.

### Claim 7 (depends on 1, 2, 3, 4)

The nucleic acid construct of any one of claims 1-4, wherein the non-natural nucleotide base is selected from the group consisting of xanthosine, isoguanosine, deoxyxanthosine, deoxyisoguanosine, isocytosine, deoxyisocytosine, 6-amino-5-nitro-3-(1′-beta-D-2′-ribofuranosyl)-2(1H)-pyridone, 6-amino-5-nitro-3-(1′-beta-D-2′-deoxyribofuranosyl)-2(1H)-pyridone, 2-amino-8- (1′-beta-D-2′-ribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one, and 2-amino-8-(1′-beta-D-2′-deoxyribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one.

### Claim 8 (depends on 7)

The nucleic acid construct of claim 7, wherein the non-natural nucleotide base is selected from the group consisting of 6-amino-5-nitro-3-(1′-beta-D-2′-ribofuranosyl)-2(1H)-pyridone or a 6-amino-5-nitro-3-(1′-beta-D-2′-deoxyribofuranosyl)-2(1H)-pyridone, 2-amino-8-(1′-beta-D-2′-ribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one, and 2-amino-8-(1′-beta-D-2′-deoxyribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one.

### Claim 9 (depends on 7)

The nucleic acid construct of claim 7, wherein the non-natural nucleotide base is a 2-amino-8-(1′-beta-D-2′-ribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one or a 2-amino-8-(1′-beta-D-2′-deoxyribofuranosyl)-imidazo[1,2-a]-1,3,5-triazin-4(8H)-one.

### Claim 10

A fusion protein comprising: a polymerase, or a fragment thereof, and an endonuclease, or a fragment thereof.

### Claim 11 (depends on 10)

The fusion protein of claim 10, wherein the polymerase is a Bst DNA polymerase, or a fragment thereof.

### Claim 12 (depends on 11)

The fusion protein of claim 11, wherein the polymerase is the large fragment of the Bst DNA polymerase.

### Claim 13 (depends on 11)

The fusion protein of claim 11, wherein the polymerase is a Bst 2.0 DNA polymerase, or a fragment thereof.

### Claim 14 (depends on 10, 11, 12, 13)

The fusion protein of any one of claims 10-13, wherein the endonuclease is an endoribonuclease.

### Claim 15 (depends on 14)

The fusion protein of claim 14, wherein the endoribonuclease is an RNase H2, or a fragment thereof.

### Claim 16 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

A primer pair comprising: a forward primer and a reverse primer, the forward and reverse primers each comprising the nucleic acid construct of any one of claims 1-9.

### Claim 17 (depends on 16)

The primer pair of claim 16, wherein the forward primer additionally comprises a terminal 3′ cap.

### Claim 18 (depends on 16, 17)

The primer pair of claim 16 or claim 17, wherein the reverse primer additionally comprises a terminal 3′ cap.

### Claim 19 (depends on 16, 17, 18)

The primer pair of any one of claims 16-18, wherein the non-natural nucleotide base of forward primer is the same as the non-natural nucleotide base of reverse primer.

### Claim 20 (depends on 16, 17, 18)

The primer pair of any one of claims 16-18, wherein the non-natural nucleotide base of forward primer is different from the non-natural nucleotide base of reverse primer.

### Claim 21 (depends on 16, 17, 18, 19, 20)

The primer pair of any one of claims 16-20, wherein the non-natural nucleotide base of forward primer is a ribonucleotide and the non-natural nucleotide base of reverse primer is a ribonucleotide.

### Claim 22 (depends on 17)

The primer pair of claim 17, wherein the non-natural nucleotide base of forward primer is a ribonucleotide and the non-natural nucleotide base of reverse primer is a deoxyribonucleotide.

### Claim 23 (depends on 16, 17, 18, 19, 20, 21, 22)

A method of detecting a target nucleic acid sequence, the method comprising:
a. providing a reaction mixture comprising
i. the primer pair of any one of claims 16-22;
ii. a sample nucleic acid that may or may not comprise the target sequence;
iii. a cleaving activity; and
iv. a polymerase activity;
b. hybridizing a first primer of the primer pair to the target nucleic acid sequence, if present, to form a first double-stranded substrate comprising the target nucleic acid sequence and a first target-specific cleavage domain;
c. cleaving the hybridized first primer with a first cleaving activity at a point within or adjacent to a first target-specific cleavage domain;
d. extending the primer with the polymerase activity to form a first template;
e. hybridizing a second primer of the primer pair to the first template to form a second double-stranded substrate comprising the target nucleic acid sequence and a second target-specific cleavage domain;
f. cleaving the hybridized second primer with a second cleaving activity at a point within or adjacent to the second cleavage domain;
g. extending the primer with the polymerase activity to form a first amplicon comprising, on a first strand, a first non-natural nucleotide base derived from the first primer;
h. cleaving the first strand at or adjacent to the first non-natural nucleotide with a third cleavage activity, creating a first nick with a 3′ hydroxyl group; and
i. extending, from the 3′ hydroxyl group, with the polymerase activity, displacing the portion of the first stand 3′ of the first nick, optionally wherein the first, second, and third cleavage activities are the same.

### Claim 24 (depends on 22)

The method of claim 22, wherein terminal 3′ end of each primer comprises a terminal 3′ cap.
